Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionChesapeake Wealth Management
Latest Disclosed Ownership2,905 shares
Latest Disclosed Value $ 404,869
Chesapeake Wealth Management ownership in GILD / Gilead Sciences, Inc.

On May 18, 2026 - Chesapeake Wealth Management filed a 13F-HR form disclosing ownership of 2,905 shares of Gilead Sciences, Inc. (CH:GILD) valued at $404,869 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 2,905 shares of Gilead Sciences, Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-18 2026-03-31 13F GILEAD SCIENCES COM 375558103 2,905 0 0.00 405 13.48 0.0696
2026-02-03 2025-12-31 13F GILEAD SCIENCES COM 375558103 2,905 517 21.65 357 34.34 0.1062
2025-11-03 2025-09-30 13F GILEAD SCIENCES COM 375558103 2,388 50 2.14 265 2.32 0.0809
2025-07-28 2025-06-30 13F GILEAD SCIENCES COM 375558103 2,338 0 0.00 259 -0.77 0.0865
2025-05-08 2025-03-31 13F GILEAD SCIENCES COM 375558103 2,338 -2,328 -49.89 262 -39.30 0.0934
2025-01-16 2024-12-31 13F GILEAD SCIENCES COM 375558103 4,666 0 0.00 431 9.97 0.1478
2024-11-07 2024-09-30 13F GILEAD SCIENCES COM 375558103 4,666 0 0.00 391 22.19 0.1335
2024-08-13 2024-06-30 13F GILEAD SCIENCES COM 375558103 4,666 -38 -0.81 320 -6.98 0.1161
2024-05-07 2024-03-31 13F GILEAD SCIENCES COM 375558103 4,704 38 0.81 345 -8.75 0.1256
2024-02-12 2023-12-31 13F GILEAD SCIENCES COM 375558103 4,666 0 0.00 378 8.02 0.1460
2023-11-16 2023-09-30 13F GILEAD SCIENCES COM 375558103 4,666 -90 -1.89 350 -4.64 0.1458
2023-08-01 2023-06-30 13F GILEAD SCIENCES COM 375558103 4,756 0 0.00 367 -7.11 0.1445
2023-04-25 2023-03-31 13F GILEAD SCIENCES COM 375558103 4,756 -41 -0.85 395 -4.14 0.1646
2023-02-23 2022-12-31 13F GILEAD SCIENCES COM 375558103 4,797 0 0.00 412 38.85 0.1803
2022-10-28 2022-09-30 13F GILEAD SCIENCES COM 375558103 4,797 0 0.00 296 -0.34 0.1351
2022-07-21 2022-06-30 13F GILEAD SCIENCES COM 375558103 4,797 0 0.00 297 4.21 0.1270
2022-04-19 2022-03-31 13F GILEAD SCIENCES COM 375558103 4,797 -122 -2.48 285 -20.17 0.1035
2022-02-03 2021-12-31 13F GILEAD SCIENCES COM 375558103 4,919 253 5.42 357 9.51 0.1202
2021-10-26 2021-09-30 13F GILEAD SCIENCES COM 375558103 4,666 0 0.00 326 1.56 0.1166
2021-07-29 2021-06-30 13F GILEAD SCIENCES COM 375558103 4,666 0 0.00 321 6.29 0.1041
2021-04-26 2021-03-31 13F GILEAD SCIENCES COM 375558103 4,666 -336 -6.72 302 3.78 0.1011
2021-02-05 2020-12-31 13F GILEAD SCIENCES COM 375558103 5,002 0 0.00 291 -7.91 0.0991
2020-11-12 2020-09-30 13F GILEAD SCIENCES COM 375558103 5,002 0 0.00 316 -17.92 0.1181
2020-08-11 2020-06-30 13F GILEAD SCIENCES COM 375558103 5,002 0 0.00 385 2.94 0.1532
2020-04-29 2020-03-31 13F GILEAD SCIENCES COM 375558103 5,002 -100 -1.96 374 12.65 0.1728
2020-01-29 2019-12-31 13F GILEAD SCIENCES COM 375558103 5,102 -350 -6.42 332 -4.05 0.1280
2019-10-25 2019-09-30 13F GILEAD SCIENCES COM 375558103 5,452 -114 -2.05 346 -7.98 0.1410
2019-08-01 2019-06-30 13F GILEAD SCIENCES COM 375558103 5,566 -820 -12.84 376 -9.40 0.1572
2019-04-17 2019-03-31 13F GILEAD SCIENCES COM 375558103 6,386 -150 -2.29 415 1.47 0.1824
2019-02-06 2018-12-31 13F GILEAD SCIENCES COM 375558103 6,536 -375 -5.43 409 -23.41 0.2025
2018-11-14 2018-09-30 13F GILEAD SCIENCES COM 375558103 6,911 0 0.00 534 8.98 0.2374
2018-08-07 2018-06-30 13F GILEAD SCIENCES COM 375558103 6,911 -160 -2.26 490 -8.24 0.2260
2018-06-04 2018-03-31 13F GILEAD SCIENCES COM 375558103 7,071 7,071 534 0.2466
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.